In Silico/In Vitro Strategies Leading to the Discovery of New Nonribosomal Peptide and Polyketide Antibiotics Active against Human Pathogens

Antibiotics are majorly important molecules for human health. Following the golden age of antibiotic discovery, a period of decline ensued, characterised by the rediscovery of the same molecules. At the same time, new culture techniques and high-throughput sequencing enabled the discovery of new mic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sami Khabthani, Jean-Marc Rolain, Vicky Merhej
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/335c42cedcb44aabae4c02720d7eadaf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:335c42cedcb44aabae4c02720d7eadaf
record_format dspace
spelling oai:doaj.org-article:335c42cedcb44aabae4c02720d7eadaf2021-11-25T18:24:55ZIn Silico/In Vitro Strategies Leading to the Discovery of New Nonribosomal Peptide and Polyketide Antibiotics Active against Human Pathogens10.3390/microorganisms91122972076-2607https://doaj.org/article/335c42cedcb44aabae4c02720d7eadaf2021-11-01T00:00:00Zhttps://www.mdpi.com/2076-2607/9/11/2297https://doaj.org/toc/2076-2607Antibiotics are majorly important molecules for human health. Following the golden age of antibiotic discovery, a period of decline ensued, characterised by the rediscovery of the same molecules. At the same time, new culture techniques and high-throughput sequencing enabled the discovery of new microorganisms that represent a potential source of interesting new antimicrobial substances to explore. The aim of this review is to present recently discovered nonribosomal peptide (NRP) and polyketide (PK) molecules with antimicrobial activity against human pathogens. We highlight the different in silico/in vitro strategies and approaches that led to their discovery. As a result of technological progress and a better understanding of the NRP and PK synthesis mechanisms, these new antibiotic compounds provide an additional option in human medical treatment and a potential way out of the impasse of antibiotic resistance.Sami KhabthaniJean-Marc RolainVicky MerhejMDPI AGarticlenew NRP-PK antibioticsin silico/in vitro strategieshuman pathogensbottom-up approachBiology (General)QH301-705.5ENMicroorganisms, Vol 9, Iss 2297, p 2297 (2021)
institution DOAJ
collection DOAJ
language EN
topic new NRP-PK antibiotics
in silico/in vitro strategies
human pathogens
bottom-up approach
Biology (General)
QH301-705.5
spellingShingle new NRP-PK antibiotics
in silico/in vitro strategies
human pathogens
bottom-up approach
Biology (General)
QH301-705.5
Sami Khabthani
Jean-Marc Rolain
Vicky Merhej
In Silico/In Vitro Strategies Leading to the Discovery of New Nonribosomal Peptide and Polyketide Antibiotics Active against Human Pathogens
description Antibiotics are majorly important molecules for human health. Following the golden age of antibiotic discovery, a period of decline ensued, characterised by the rediscovery of the same molecules. At the same time, new culture techniques and high-throughput sequencing enabled the discovery of new microorganisms that represent a potential source of interesting new antimicrobial substances to explore. The aim of this review is to present recently discovered nonribosomal peptide (NRP) and polyketide (PK) molecules with antimicrobial activity against human pathogens. We highlight the different in silico/in vitro strategies and approaches that led to their discovery. As a result of technological progress and a better understanding of the NRP and PK synthesis mechanisms, these new antibiotic compounds provide an additional option in human medical treatment and a potential way out of the impasse of antibiotic resistance.
format article
author Sami Khabthani
Jean-Marc Rolain
Vicky Merhej
author_facet Sami Khabthani
Jean-Marc Rolain
Vicky Merhej
author_sort Sami Khabthani
title In Silico/In Vitro Strategies Leading to the Discovery of New Nonribosomal Peptide and Polyketide Antibiotics Active against Human Pathogens
title_short In Silico/In Vitro Strategies Leading to the Discovery of New Nonribosomal Peptide and Polyketide Antibiotics Active against Human Pathogens
title_full In Silico/In Vitro Strategies Leading to the Discovery of New Nonribosomal Peptide and Polyketide Antibiotics Active against Human Pathogens
title_fullStr In Silico/In Vitro Strategies Leading to the Discovery of New Nonribosomal Peptide and Polyketide Antibiotics Active against Human Pathogens
title_full_unstemmed In Silico/In Vitro Strategies Leading to the Discovery of New Nonribosomal Peptide and Polyketide Antibiotics Active against Human Pathogens
title_sort in silico/in vitro strategies leading to the discovery of new nonribosomal peptide and polyketide antibiotics active against human pathogens
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/335c42cedcb44aabae4c02720d7eadaf
work_keys_str_mv AT samikhabthani insilicoinvitrostrategiesleadingtothediscoveryofnewnonribosomalpeptideandpolyketideantibioticsactiveagainsthumanpathogens
AT jeanmarcrolain insilicoinvitrostrategiesleadingtothediscoveryofnewnonribosomalpeptideandpolyketideantibioticsactiveagainsthumanpathogens
AT vickymerhej insilicoinvitrostrategiesleadingtothediscoveryofnewnonribosomalpeptideandpolyketideantibioticsactiveagainsthumanpathogens
_version_ 1718411186429493248